| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 03/03/2004 | EP1392868A1 Method for the synthesis of dna sequences |
| 03/03/2004 | CN1478483A Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699978 Linker nucleoside, and production and use of the same |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 02/26/2004 | WO2004016805A2 Immunostimulatory nucleic acids |
| 02/26/2004 | WO2004016755A2 Amplification of target nucleotide sequence without polymerase chain reaction |
| 02/26/2004 | WO2004016635A2 Partial and full agonists of a1 adenosine receptors |
| 02/26/2004 | WO2003091311A8 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/26/2004 | WO2003045334A3 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 02/26/2004 | WO2003040144A3 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/26/2004 | WO2003006475A3 Method for preparation of lna phosphoramidites |
| 02/26/2004 | US20040039190 Suspending adenine in N-methylimidazole, stirring under nitrogen atmosphere while adding heptanoic anhydride, heating, the cooling to crystallize; avoids formation of geometrical isomers |
| 02/26/2004 | US20040039032 3,4-dienoyl allene compounds, useful for treating diabetes, heart diseases (including angina and congestive heart failure), and peripheral vascular diseases |
| 02/26/2004 | US20040038928 N-pyrazole A2A receptor agonists |
| 02/26/2004 | US20040038350 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
| 02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
| 02/26/2004 | US20040038215 Oligonucleotide tagged nucleoside triphosphates (OTNTPs) for genetic analysis |
| 02/26/2004 | CA2495370A1 Partial and full agonists of a1 adenosine receptors |
| 02/26/2004 | CA2493753A1 Immunostimulatory nucleic acids |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/25/2004 | EP1390545A1 Biological sample processing methods and compositions that include surfactants |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390376A1 Preparation and isolation of indolocarbazole glycosides |
| 02/25/2004 | EP1389970A2 Compositions and methods of double-targeting virus infections and cancer cells |
| 02/25/2004 | EP1389909A1 Antimicrobial compounds and methods for their use |
| 02/25/2004 | EP1017704B1 Use of a pentopyranosyl nucleoside containing conjugate for producing an array |
| 02/25/2004 | EP0758897B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/25/2004 | CN1478096A L-nucleic acid derivatives and processes for synthesis thereof |
| 02/24/2004 | US6696555 3'-Desoxypentopyranosyl nucleic acid, its production and its use |
| 02/24/2004 | US6696252 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
| 02/24/2004 | US6695943 Method of manufacturing a soft hearing aid |
| 02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
| 02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 02/19/2004 | US20040034213 Process for producing a ribofuranose |
| 02/19/2004 | US20040034212 Nucleoside modifications by palladium catalyzed methods |
| 02/19/2004 | US20040033981 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 02/19/2004 | US20040033973 Nucleosides with enhanced binding affinity; drug screening |
| 02/19/2004 | US20040033967 Alkylated hexitol nucleoside analogues and oligomers thereof |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/18/2004 | EP1389216A2 Avermectins substituted in the 4"-position having pesticidal properties |
| 02/18/2004 | EP1070079B1 Method for the production of pentopyranosyl nucleosides |
| 02/17/2004 | US6693193 Coupling an n- and o-protected 2,3-dihydroxy-pyrrolidine to the 2-position and deprotecting |
| 02/17/2004 | US6693187 Enhancing nuclease resistance |
| 02/12/2004 | WO2004013298A2 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections |
| 02/12/2004 | WO2004012746A2 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 02/12/2004 | WO2004012687A2 Crystalline and amorphous forms of beta-l-2'-deoxythymidine |
| 02/12/2004 | WO2004012667A2 Photoactivated anti-viral and anti-cancer agent |
| 02/12/2004 | WO2003095608A3 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | US20040029820 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/12/2004 | US20040029139 System for simultaneous detection of multiple binding events in the same reaction |
| 02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 02/12/2004 | US20040028815 Combinatorial synthesis |
| 02/12/2004 | CA2498231A1 Photoactivated anti-viral and anti-cancer agent |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/10/2004 | US6689763 Antibiotics AA-896 |
| 02/10/2004 | US6689761 Compound j, nucleoside analog hiv reverse transcriptase inhibitor 3tc and azt |
| 02/10/2004 | CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/05/2004 | WO2004011681A1 Microfluidic device including purification column with excess diluent, and method |
| 02/05/2004 | WO2004011481A1 Phosmidosine derivative and process for producing the same |
| 02/05/2004 | WO2004011480A1 5' choline phosphate 3'-azido 3'-deoxythymidine |
| 02/05/2004 | WO2004011479A1 Inhibitors of rna dependent rna polymerase and uses thereof |
| 02/05/2004 | WO2004011478A2 Anti-viral 7-deaza d-nucleosides and uses thereof |
| 02/05/2004 | WO2003089670A3 Reagents for monitoring nuclei acid amplification and methods of using same |
| 02/05/2004 | WO2003087118A3 Method for producing beta-l-2'deoxy-thymidine |
| 02/05/2004 | WO2003066878A3 Nucleic acid analysis using layered expression scanning |
| 02/05/2004 | US20040024725 Regulated apoptosis |
| 02/05/2004 | US20040024196 Phase transfer catalyzed glycosidation of an indolocarbazole |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040023901 Novel nucleoside bases and phosphate moiety mimics optionally having sugar-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acceptable salt, a pharmaceutically acceptable prodrug, or a |
| 02/05/2004 | US20040023900 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040023240 Combinatorial production of nucleotide and nucleoside(xitp)analogues |
| 02/05/2004 | CA2492607A1 Anti-viral 7-deaza d-nucleosides and uses thereof |
| 02/05/2004 | CA2492450A1 Microfluidic device including purification column with excess diluent, and method |
| 02/04/2004 | EP1385829A2 Nucleic acid labeling compounds |
| 02/04/2004 | CN1137132C Cyanoribofuranoside compound and its preparing method |
| 02/03/2004 | USRE38416 Cross-linking oligonucleotides |
| 02/03/2004 | US6686463 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 02/03/2004 | US6686462 Antiviral compounds and methods of administration |
| 02/03/2004 | US6686461 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/03/2004 | US6686385 Anhydro sugar derivatives of indolocarbazoles |
| 02/03/2004 | US6686152 Methods employing oligonucleotide-binding e-tag probes |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2067151C Aica riboside analogs |
| 01/29/2004 | WO2004009611A2 Multiple layer membrane and method for fabrication thereof |
| 01/29/2004 | WO2004009610A2 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases |
| 01/29/2004 | WO2004009609A2 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 01/29/2004 | WO2004009020A2 Pyrrolopyrimidine thionucleoside analogs as antivirals |
| 01/29/2004 | US20040019232 Analogs of phosphonate and bisphosphonate compounds based on bone resorption suppressors (alendronic acid), viricides (cidofovir) and antineoplastic agents (bemcitabine); nontoxic; bioavailability; side effects reduction |
| 01/29/2004 | US20040019191 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 01/29/2004 | US20040018995 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; antidiabetic agents |
| 01/29/2004 | US20040018993 Avermectin derivatives |
| 01/29/2004 | US20040018150 Screening prodrugs of methoxyphosphonate nucleotide analogues to identify prodrugs selectively targeting desired tissues with antiviral or antitumor activity. This method has led to the identification of novel mixed ester-amidates of PMPA for |
| 01/29/2004 | CA2493816A1 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383510A1 Bisphosphonate conjugates and methods of making and using the same |